Growth Metrics

Standard Biotools (LAB) Income from Continuing Operations (2010 - 2026)

Standard Biotools (LAB) reported Income from Continuing Operations of 14626000.0 for Q1 2026, up 37.47% year-over-year from 10639696.26 in Q1 2025, and down 117.73% on a QoQ basis from 82477000.0 in Q4 2025.

Standard Biotools (LAB) has 17 years of Income from Continuing Operations data on file, last reported at 14626000.0 in Q1 2026.

  • Quarterly Income from Continuing Operations rose 37.47% year-over-year to 14626000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18485000.0 (up 158.58% YoY) and the FY2025 annual result came in at 9706000.0, up 139.48% from the prior year.
  • Income from Continuing Operations retreated to 14626000.0 in Q1 2026 per LAB's latest filing, from 82477000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 82477000.0 in Q4 2025 and bottomed at 76262000.0 in Q1 2022.
  • The 5-year median for Income from Continuing Operations is 21047000.0 (2023), against an average of 14748529.41.
  • The widest annual swing landed in 2022, when Income from Continuing Operations sank 305.82%; it then jumped 1156.13% in 2023.
  • Tracing LAB's Income from Continuing Operations over 5 years: stood at 1958000.0 in 2022, then jumped by 1156.13% to 20679000.0 in 2023, then jumped by 89.47% to 39180000.0 in 2024, then surged by 110.51% to 82477000.0 in 2025, then plunged by 117.73% to 14626000.0 in 2026.
  • Per Business Quant, the three latest LAB Income from Continuing Operations figures stand at 14626000.0 (Q1 2026), 82477000.0 (Q4 2025), and 31684000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 220.30 Mn
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn -14.63 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -14.63 Mn
Dec 31, 2025 82.48 Mn
Sep 30, 2025 -31.68 Mn
Jun 30, 2025 -17.68 Mn
Mar 31, 2025 -23.39 Mn
Dec 31, 2024 39.18 Mn
Sep 30, 2024 -21.90 Mn
Jun 30, 2024 -25.44 Mn
Mar 31, 2024 -32.16 Mn
Dec 31, 2023 20.68 Mn
Sep 30, 2023 -21.05 Mn
Jun 30, 2023 -17.04 Mn
Mar 31, 2023 -16.88 Mn
Dec 31, 2022 -1.96 Mn
Sep 30, 2022 -29.44 Mn
Jun 30, 2022 -63.55 Mn
Mar 31, 2022 -76.26 Mn
Sep 30, 2021 -13.84 Mn
Jun 30, 2021 -17.16 Mn
Mar 31, 2021 -18.79 Mn
Dec 31, 2020 -18.03 Mn
Sep 30, 2020 -6.04 Mn
Jun 30, 2020 -13.06 Mn
Mar 31, 2020 -15.98 Mn
Dec 31, 2019 -12.69 Mn
Sep 30, 2019 -12.89 Mn
Jun 30, 2019 -13.80 Mn
Mar 31, 2019 -25.47 Mn
Dec 31, 2018 -14.81 Mn
Sep 30, 2018 -14.75 Mn
Jun 30, 2018 -16.24 Mn
Mar 31, 2018 -13.25 Mn
Dec 31, 2017 -10.41 Mn
Sep 30, 2017 -15.94 Mn
Jun 30, 2017 -16.96 Mn
Mar 31, 2017 -17.18 Mn
Dec 31, 2016 -17.70 Mn
Sep 30, 2016 -19.80 Mn
Jun 30, 2016 -18.62 Mn
Mar 31, 2016 -19.88 Mn
Dec 31, 2015 -12.88 Mn
Sep 30, 2015 -9.27 Mn
Jun 30, 2015 -15.24 Mn
Mar 31, 2015 -15.93 Mn
Dec 31, 2014 -10.94 Mn
Sep 30, 2014 -13.79 Mn
Jun 30, 2014 -12.68 Mn
Mar 31, 2014 -15.41 Mn
Dec 31, 2013 -4.64 Mn
Sep 30, 2013 -4.29 Mn
Jun 30, 2013 -4.05 Mn
Mar 31, 2013 -3.55 Mn
Dec 31, 2012 -3.60 Mn
Sep 30, 2012 -4.15 Mn
Jun 30, 2012 -4.58 Mn
Mar 31, 2012 -6.69 Mn
Dec 31, 2011 -3.46 Mn
Sep 30, 2011 -4.49 Mn
Jun 30, 2011 -7.19 Mn
Mar 31, 2011 -7.34 Mn
Dec 31, 2010 -3.08 Mn
Sep 30, 2010 -3.38 Mn
Jun 30, 2010 -4.82 Mn